Purchases and Sales Made in Q3 2024 in Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX) during Q3 2024. The information is specifically focused on institutions that hold shares of VERTEX PHARMACEUTICALS INC .
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-119K- 5.68% |
$54.6M - $60M
|
1.97M
$945M
|
|
Nov 14, 2024
Q3 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-119K- 4.91% |
$54.7M - $60.1M
|
2.3M
$1.1B
|
|
Nov 13, 2024
Q3 2024
|
Glenmede Trust CO Na
Philadelphia, PA |
SELL
|
- |
-129K- 96.92% |
$59.2M - $65.1M
|
4.09K
$1.96M
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-142K- 82.89% |
$65.5M - $72M
|
29.4K
$14.1M
|
|
Nov 14, 2024
Q3 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-143K- 5.53% |
$65.7M - $72.3M
|
2.44M
$1.17B
|
|
Nov 14, 2024
Q3 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-146K- 73.79% |
$67M - $73.6M
|
51.7K
$24.8M
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-168K- 6.63% |
$77.2M - $84.9M
|
2.37M
$1.13B
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-171K- 51.64% |
$78.9M - $86.7M
|
161K
$76.9M
|
|
Nov 01, 2024
Q3 2024
|
Assetmark, Inc
|
SELL
|
- |
-176K- 46.35% |
$81.1M - $89.2M
|
204K
$97.7M
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-183K- 8.9% |
$84.2M - $92.5M
|
1.87M
$897M
|
|
Nov 14, 2024
Q3 2024
|
Caisse De Depot Et Placement Du Quebec
Montreal, A8 |
SELL
|
- |
-184K- 33.06% |
$84.5M - $92.9M
|
372K
$178M
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-220K- 6.76% |
$101M - $111M
|
3.04M
$1.46B
|
|
May 14, 2025
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-220K- 6.76% |
$101M - $111M
|
3.04M
$1.46B
|
|
Nov 14, 2024
Q3 2024
|
Apg Asset Management N.V.
Amsterdam, P7 |
SELL
|
- |
-234K- 65.35% |
$108M - $118M
|
124K
$59.4M
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-249K- 82.15% |
$115M - $126M
|
54.2K
$26M
|
|
Nov 14, 2024
Q3 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-322K- 71.07% |
$148M - $163M
|
131K
$62.8M
|
|
Oct 03, 2024
Q3 2024
|
Amf Tjanstepension Ab
|
SELL
|
- |
-382K- 69.45% |
$176M - $193M
|
168K
$80.4M
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-389K- 6.16% |
$179M - $197M
|
5.94M
$2.84B
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-444K- 20.06% |
$204M - $224M
|
1.77M
$847M
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-545K- 36.73% |
$251M - $275M
|
938K
$449M
|
|
Feb 07, 2025
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-545K- 36.73% |
$251M - $275M
|
938K
$449M
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-704K- 34.13% |
$324M - $356M
|
1.36M
$651M
|
|
Nov 04, 2024
Q3 2024
|
Mayflower Financial Advisors, LLC
|
SELL
|
- |
-728K- 99.8% |
$335M - $368M
|
1.48K
$710K
|